Schedule

Monday, July 11, 2022

Tuesday, July 12, 2022

Wednesday, July 13, 2022

Register

Venue and Accommodations

The Adherence 2022 conference venue will be the Mayflower Hotel, which is located at 1127 Connecticut Ave NW, Washington, DC, USA, 20036. IAPAC has secured a discounted room rate at the Mayflower Hotel of $209/night plus sales/occupancy tax for the nights of July 10-14, 2022.

Room reservations may be made by clicking here.

Alternatively, you can make your reservation by calling +1-877-212-5752 and referencing the International Association of Providers of AIDS Care room block.

Submit an Abstract

The Adherence 2022 conference will feature oral abstract and e-poster sessions. The portal is open for submissions through the two timeframes specified below for standard abstract and late-breaker abstract submission. Abstract submissions on data that have already been published in full in a peer-reviewed journal(s) or presented at a major conference (e.g., CROI, IAS/AIDS) are not eligible for submission. However, the conference organizers will accept abstract submissions on data previously or concurrently submitted to other conferences, if permissible by their guidelines.

KEY DATES

Following are key dates relevant to abstract submissions:

• Abstract Submission Deadline – April 1, 2022
• Late-Breaker Abstract Submissions – April 25-29, 2022
• Abstract Disposition Announcements – May 27, 2022
• Deadline to Withdraw Abstract/Change Presenting Author – June 10, 2022

CALL FOR ABSTRACTS

Abstract submissions are encouraged in a wide variety of specific domains, including:

• Antiretroviral therapy medication and medication adherence
• Linkage, retention, and re-engagement in HIV care
• Adherence and engagement in biomedical HIV prevention strategies
• Implementation science related to HIV care continuum optimization
• Community engagement in planning, implementing, and monitoring HIV responses

Within these areas we encourage coverage of:

• Advances in basic science
• Innovative monitoring strategies
• Longitudinal or observational data
• Innovations in modeling and biopsychosocial theory
• Intervention development, implementation, and/or outcomes
• Dissemination/implementation of evidence-based approaches
• Operations research, demonstration projects, and practice-based approaches
• Health care policy and financing at local, state, and national levels
• Resource, structural, and service delivery issues and innovations
• Implementation science design, evidence, and real-world applicability
• Service delivery adaptations and innovations in the context of COVID-19
• Mitigation of HIV service disruption within the context of public health crises

Particularly as applied to key and disproportionately affected populations and settings:

• Treatment naïve, treatment experienced
• Individuals living with mental and/or physical health challenges
• Concomitant diseases (e.g., HBV, HCV, TB)
• Comorbid conditions (e.g., diabetes, hypertension)
• Syndemic conditions (e.g., mental health, substance use)
• Resource-constrained settings and geographies
• Key and vulnerable populations:
  • Men who have sex with men
  • Transgender individuals
  • Women in high HIV incidence areas
  • Female and male sex workers
  • Pregnant women
  • Children and adolescents
  • Substance users
  • Incarcerated or recently released individuals
  •  Homeless and/or marginally housed individuals

ABSTRACT SUBMISSION

Abstracts must be submitted online by 5 pm ET, April 1, 2022. Submitted abstracts will be considered for oral or e-poster presentation. Submitted abstracts should report information not previously published, or intended to be published, prior to June 10, 2022.

It is the responsibility of the presenting author to ensure accuracy of content, spelling, and presentation. Abstracts will be published as submitted, subject to reformatting that may be required by IAPAC.

ABSTRACT FORMAT

Abstract contents will be either research-based data using established scientific methods or demonstrate experience and information from individuals or institutions working in the field. Please follow one of two structured formats (A or B), indicating in bold the four parts of your abstract:

Format A: Data-Driven Abstracts

1. Background: a concise statement of the issues evaluated
2. Methods: the investigational model used
3. Results: specific findings
4. Conclusions: summary of findings, supported by results

Format B: Program Descriptions and Case Studies

1. Introduction: a concise statement of the issues addressed
2. Description: a description of the project, case study, experience, or intervention
3. Lessons Learned: project results, implementation issues, and/or case study solutions
4. Recommendations: further recommendations or next steps

GENERAL GUIDELINES

Following are some general guidelines for individuals interested in submitting an abstract(s):

• The abstract must NOT contain more than 300 words.
• Acceptable abstracts shall contain a concise statement of the research, define the precise subject of the presentation, and be related to the main theme or a sub-theme of the conference.
• Literature references and acknowledgements should not form any part of the abstract’s content.
• Figures and tables are acceptable, subject to high definition/quality guidance to be provided.
• The author is responsible for grammatical and factual details, and may edit an abstract after it has been submitted up to May 27, 2022.
• All abstracts must be submitted in English (without exception).
• Sub-specialty jargon should be avoided, reflecting the interdisciplinary nature of the conference.
• Define all abbreviations and concepts in your abstract at first use.
• For therapeutic agents, only generic names may be used (trade names are not permitted).

ABSTRACT SUBMISSION AND ACCEPTANCE

All abstracts must be submitted online no later than 5:00 pm ET, April 1, 2022. Submissions will be acknowledged upon successful submission via the site. Faxed or mailed abstracts will not be considered.

Please record your abstract number. The number assigned to your abstract when it is submitted online will be the abstract number referenced throughout the conference, including in the Program and Abstracts book, during the Oral Abstract sessions, and during the e-Poster Session. A notice of acceptance or rejection will be sent via e-mail no later than May 27, 2022. The disposition of each abstract will be sent via e-mail only to the submitting author identified on the submission form for that abstract. That contact will be responsible for sharing the disposition with all other authors of the abstract (including the presenting author).

Accepted abstracts will be in one of two categories:

1.      Oral Abstract presentation
2.      e-Poster Abstract presentation

Presenting authors agree to register for and attend the conference as scheduled in either Oral Abstract sessions or the e-Poster Session. Oral abstract and e-poster presenters are responsible for their own travel and accommodation expenses, as well as the applicable registration fees.

Note that only the abstracts of paid conference registrants will be included in the final Program and Abstracts Book. Accepted abstracts will be published in the conference proceedings. Abstracts are considered official communication to IAPAC. Submission of an abstract implies permission to publish abstracts (including in the Journal of the International Association of Providers of AIDS Care [JIAPAC]) and online posting, if accepted. E-posters files must be transferred to IAPAC by June 3, 2022. any electronic presentation and handouts will be transferred to IAPAC.

To reiterate, all abstract submissions must be received online by 5:00 pm ET, April 1, 2022. It is strongly recommended that you do not wait until the last minute to submit your abstract(s). You may review/edit submissions from now until 5:00 pm ET, May 27, 2022. Abstracts may be withdrawn or the presenter may be changed until June 10, 2022.

Call for Nominations

On behalf of the Adherence 2022 conference, and in recognition of the impact the conference delegates are making, IAPAC and the conference Co-Chairs will be presenting 2 awards to researchers who are making a scientific impact within the field of HIV adherence research.

IAPAC “Rising Star” Award for an Early-Career HIV Adherence Researcher

IAPAC would like to recognize an early career researcher (i.e., within 10 years of their terminal degree) who has already demonstrated expertise and impact in any aspect of HIV adherence research. The recipient will be chosen based on their potential to move the field forward in new and exciting directions.

IAPAC Outstanding Contribution to HIV Adherence Award for a Senior Researcher

IAPAC would like to recognize a senior researcher (i.e., more than 10 years after their terminal degree) who has significantly contributed to the field of HIV adherence, with evidence of scientific impact. The recipient’s mentorship of other investigators also will be considered during the selection process.

Please nominate yourself or another by sending the following information to jhess@iapac.org with the subject line Adherence 2022 Nomination by June 15, 2022:

• Biosketch
  • Figures, tables, or graphics are not allowed in the biosketch. Do not embed or attach files (e.g. video, graphics, sound, data).
  • The biosketch may not exceed  5 pages per person.
• One letter (max 1 page) describing the nominee’s impact on the field of HIV adherence research; more than one person may contribute to the letter.

Conference Archives

• Adherence 2021
• Adherence 2020
• Adherence 2019
• Adherence 2018
• Adherence 2017
• Adherence 2016
• Adherence 2015
• Adherence 2014
• Adherence 2013
• Adherence 2012
• Adherence 2011
• Adherence 2010
• Adherence